These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 15304503)
1. Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. Beher D; Clarke EE; Wrigley JD; Martin AC; Nadin A; Churcher I; Shearman MS J Biol Chem; 2004 Oct; 279(42):43419-26. PubMed ID: 15304503 [TBL] [Abstract][Full Text] [Related]
2. Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. Takahashi Y; Hayashi I; Tominari Y; Rikimaru K; Morohashi Y; Kan T; Natsugari H; Fukuyama T; Tomita T; Iwatsubo T J Biol Chem; 2003 May; 278(20):18664-70. PubMed ID: 12637581 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop? Knappenberger KS; Tian G; Ye X; Sobotka-Briner C; Ghanekar SV; Greenberg BD; Scott CW Biochemistry; 2004 May; 43(20):6208-18. PubMed ID: 15147205 [TBL] [Abstract][Full Text] [Related]
4. Intra- or intercomplex binding to the gamma-secretase enzyme. A model to differentiate inhibitor classes. Clarke EE; Churcher I; Ellis S; Wrigley JD; Lewis HD; Harrison T; Shearman MS; Beher D J Biol Chem; 2006 Oct; 281(42):31279-89. PubMed ID: 16899457 [TBL] [Abstract][Full Text] [Related]
5. An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1. Sala Frigerio C; Kukar TL; Fauq A; Engel PC; Golde TE; Walsh DM Biochemistry; 2009 Nov; 48(46):10894-904. PubMed ID: 19821615 [TBL] [Abstract][Full Text] [Related]
7. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211 [TBL] [Abstract][Full Text] [Related]
8. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Ozols V; Fauq A; Golde TE; Koo EH J Biol Chem; 2003 Aug; 278(34):31831-7. PubMed ID: 12805356 [TBL] [Abstract][Full Text] [Related]
9. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Golde TE; Koo EH J Biol Chem; 2003 Aug; 278(33):30748-54. PubMed ID: 12777371 [TBL] [Abstract][Full Text] [Related]
10. The same gamma-secretase accounts for the multiple intramembrane cleavages of APP. Zhao G; Tan J; Mao G; Cui MZ; Xu X J Neurochem; 2007 Mar; 100(5):1234-46. PubMed ID: 17241131 [TBL] [Abstract][Full Text] [Related]
11. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase. Gamerdinger M; Clement AB; Behl C Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496 [TBL] [Abstract][Full Text] [Related]